CTOs on the Move


 
AcelRx Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. The Company`s product candidates, DSUVIA™ (known as ARX-04 outside of the United States) and ZALVISO®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. DSUVIA is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. The Phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.acelrx.com
  • 351 Galveston Drive
    Redwood City, CA USA 94063
  • Phone: 650.216.3500

Executives

Name Title Contact Details

Funding

AcelRx raised $27.5M on 01/20/2021

Similar Companies

The Bright Spot for Health

The Bright Spot for Health is a Wichita, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sarah A Todd Memorial Home

Sarah A Todd Memorial Home is a Carlisle, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TropiClean

Tropiclean Pet Products, a division of Cosmos Corporation, has been providing pet owners and professionals with innovative solutions in the pet care category for over 20 years.

F-D-C Reports

F-D-C Reports, Inc. is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Society of the State of New York

Medical Society of the State of New York is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.